AGP Picks
View all

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

Press releases published on July 21, 2026

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions
Smile Doctors Appoints Jeff Knudson as CFO to Help Scale Next Phase of Growth
AssistRx and Medisafe Unite to Power Smarter, More Connected Patient Engagement
 VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience
Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
Vaxart to Participate in BTIG Biotechnology Conference 2026
Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Update Bahamas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.